Google Cloud Platform Blog
Product updates, customer stories, and tips and tricks on Google Cloud Platform
Alacris helps better match cancer patients with drug therapies using Google Cloud Platform
January 7, 2015
Today's guest post is from Dr. Alexander Kühn, Head of Bioinformatics at
Alacris Theranostics
, a Berlin-based spin-off company of the Max Planck Institute for Molecular Genetics, which uses next generation sequencing and other genomics data through its predictive modeling system
ModCell™
for drug development and personalized medicine in oncology.
Cancer is a complex disease; differences in the genetic make-up of individuals as well as their tumors make every cancer patient unique. Yet, the majority of current medical practice fails to recognize this individuality and treats many patients identically, leading to wide variations in response to therapy. Typically, only 25% of patients benefit from the (often expensive) treatment they are given, with many suffering serious side effects. Even if some progress is visible, cancer drug therapy still seems to be largely based on a trial and error principle.
Computer models have enormous potential to overcome this mismatch for patients as well as for healthcare costs. We at Alacris use computer models based on millions of data points to carry out virtual clinical trials and virtual patient modeling. In order to better match patients to therapies and therapies to patients, Alacris developed the ModCell™ system.
ModCell™ generates a 'Virtual Patient' model for individualized prediction of therapy outcome. First, an individual patient and his or her tumor is analysed on the molecular level. This patient-specific genetic information is subsequently integrated into a cancer model. Thus, the ModCell™ system combines all available molecular information about a patient's disease with the sum of the molecular and mechanistic knowledge about cancer as a whole within a patient-specific tumor model. Using this model, we can simulate the effects of hundreds of different drugs or drug combinations on the patient tumor right on a computer.
We used the ModCell™ system to simulate the effects of about 100 molecular targeted anti-cancer as well as non anti-cancer drugs/compounds on more than 700 different cancer cell lines, originating from 24 diverse tissue types. Molecular data of cancer cell lines were provided by the Cancer Cell Line Encyclopedia (CCLE). For each different cell line available, virtual models comprised of more than 6,000 parameters were generated. The models were employed to predict cell-line specific responses to a range of drugs by simulating a concentration of varying amounts for each compound (detailed description of the simulation approach can be found here). In total, we generated more than 5 million different models, each of which was expected to need up to one minute to be solved numerically and to produce about 500 kB of simulation data. This results in a simulation time of more than 3,000 days, if run on a single core, and more than 2 TB of data. Google Cloud Platform enabled us to handle this enormous simulation workload:
Here’s a breakdown of the steps we took to set up our workload on Google Compute Engine:
Set up a single n1-highmen-8 instance as an SSH gateway
Connected and exported a persistent 1 TB disk with Network File System version 4 (
NFSv4
)
Created 125 VM instances, with a total of 1,000 cores, and connected these to the exported disk
Used open source project
TaskManager
to control and schedule the generated cluster
TaskManager enabled us to execute the job on a single core by distributing each of the 5 million simulation jobs over the whole cluster
TaskManager enabled us to operate at full capacity and in parallel over several days. Results of each simulation were stored on the shared storage disk.
Simulation results are now being used to calculate the inhibition of cell growth, which will be compared to pharmacological profiles available from Cancer Cell Line Encyclopedia (CCLE). Potentially, these results will facilitate identification of cancer-related signal transduction pathways that are not yet covered in the model, and also further our understanding of the functional consequences of mutations at both the molecular pathway and cellular level. Moreover, we will gain insight into drug action at the molecular level and analyze cross-talk and potential redundancies between pathways. Using this information, the ModCell™ system can be expanded and modified, integrating the identified cancer-related signaling pathways and mutations, and additional drug information, such as drug uptake dynamics and drug metabolism.
Use of Google Cloud Platform has made it possible for us to rapidly refine and improve our modeling system, which has become about 10x faster than using the Alacris’ computer cluster (which contains only 100 cores). These improvements will help (a) to optimize personalized cancer therapy by removing some of the risks associated with classical empirically administered treatments and (b) to optimize the predictive power of virtual clinical trials to test drugs before they go into clinical trials. The goal is for this to lead to higher drug approval rates, saving time and a large fraction of the costs associated with clinical trials.
-Posted by Dr. Alexander Kühn, Head of Bioinformatics at Alacris Theranostics
No comments :
Post a Comment
Free Trial
Labels
Android
Announcement
api
app engine
Atmosphere Live
bigquery
BigTable
CDN
Cloud Console
Cloud Dataflow
Cloud Datastore
cloud endpoints
Cloud Pub/Sub
Cloud SDK
cloud sql
cloud storage
Cloudera
Compute
Compute Engine
container cluster
customer
Dev Tools
developer tools
developer-insights
Developers
Developers Console
devfests
Disaster Recovery
Encryption Keys
ESG
Event
events
GA
Go Client
Google App Engine
Google Apps
Google BigQuery
Google Cloud Deployment Manager
Google Cloud Networking
Google Cloud Platform
Google Cloud Storage
Google Compute Engine
Google Container Engine
gRPC
hadoop
Hardware
Helium
how to
IO2013
iOS
Kubernetes
Levyx
Local SSD
mapreduce
Media
Nearline
networking
open source
PaaS Solution
Partner
Pricing
Research
round-up
Server
Siggraph
solutions
Startup
Tableau
TCO
Technical
Windows
Wowza
Zync
Archive
2015
Nov
Oct
Sep
Aug
Jul
Jun
May
Apr
Mar
Feb
Jan
2014
Dec
Nov
Oct
Sep
Aug
Jul
Jun
May
Apr
Mar
Feb
Jan
2013
Dec
Nov
Oct
Sep
Aug
Jul
Jun
May
Apr
Mar
Feb
Jan
2012
Dec
Nov
Oct
Sep
Aug
Jul
Jun
May
Apr
Mar
Feb
Jan
2011
Dec
Nov
Oct
Sep
Aug
Jul
Jun
May
Apr
Mar
Feb
Jan
2010
Dec
Oct
Sep
Aug
Jul
Jun
May
Apr
Mar
Feb
Jan
2009
Dec
Nov
Oct
Sep
Aug
Jul
Jun
May
Apr
Mar
Feb
Jan
2008
Dec
Nov
Oct
Sep
Aug
Jul
Jun
May
Apr
Feed
Technical questions? Check us out on
Stack Overflow
.
Subscribe to
our monthly newsletter
.
Follow @googlecloud
No comments :
Post a Comment